Minnesota
Explore the Minnesota records currently included in this collection. Coverage is not complete.
State Laws Database: 0 records
NHGRI database archive: 54 records
Status: 14 enacted or approved; 10 proposed or pending
Most common mapped topics: Privacy (21) · Other Topics (12) · Use of Residual Newborn Screening Specimens (9)
Records in Minnesota
Showing 20 of 54; State Laws Database records appear first.
| Jurisdiction | Law or policy | Topics | Status | Summary |
|---|---|---|---|---|
| Minnesota | 2021 State Bills Minnesota 2021 HF 82NHGRI archive2021 legislative sessionPrimary source | Other Topics | Pending | Establishes a grant program within the health department to award grants to persons, organizations, and entities to fund research studies on the evidence needed to: (1) support payer reimbursement and funding of pharmacogenomics (PGx) testing; (2) determine and validate new PGx variants in diverse populations such as Native Americans and Somali groups; (3) determine ethical, legal, and social implications of PGx; (4) determine the technical aspects needed to protect data and privacy as it relates to PGx; and (5) determine the education needed for successful PGx implementation. Carries over to 2022 session. . |
| Minnesota | 2021 State Bills Minnesota 2021 HF 1492NHGRI archive2021 legislative sessionPrimary source | Privacy | Pending | Provides various rights to consumers regarding personal data. Requires certain businesses to conduct and document a data protection assessment of processing activities involving personal data, including sensitive data. Requires data controllers to obtain consent from consumers before processing sensitive data. Sensitive data is defined to include the processing of genetic or biometric data for the purpose of uniquely identifying a natural person. Carries over to 2022 session. |
| Minnesota | 2021 State Bills Minnesota 2021 HF 2414NHGRI archive2021 legislative sessionPrimary source | Health Insurance Coverage | Pending | Requires every policy, plan, certificate, or contract referred to in subdivision that provides coverage to a Minnesota resident to provide coverage for all diagnostic and preventive screenings and tests related to breast cancer, including but not limited to genetic testing, breast examination, mammography, magnetic resonance imaging, digital breast tomosynthesis, ultrasound, thermography, biopsy, and other breast cancer screening tests currently being evaluated by the federal Food and Drug Breast Cancer research Foundation. Carries over to 2022 session. |
| Minnesota | 2021 State Bills Minnesota 2021 HF 36NHGRI archive2021 legislative sessionPrimary source | Privacy | Enacted | Relates to consumer data privacy. Establishes business obligations regarding: (1) collection and disclosure of personal information; and (2) sale of personal information to third parties. Gives various rights to consumers regarding personal data. Personal information includes biometric information such as genetic information. Carries over to 2022 session. |
| Minnesota | 2021 State Bills Minnesota 2021 HF 81NHGRI archive2021 legislative sessionPrimary source | Other Topics | Pending | Requires the Minnesota Board of Pharmacy to establish a pharmacogenomics task force to evaluate and assess the current availability of pharmacogenomics statewide and to develop recommendations for making pharmacogenomics available statewide. Carries over to 2022 session. |
| Minnesota | 2021 State Bills Minnesota 2021 SF 1408NHGRI archive2021 legislative sessionPrimary source | Privacy | Pending | Provides various rights to consumers regarding personal data. Requires certain businesses to conduct and document a data protection assessment of processing activities involving personal data, including sensitive data. Requires data controllers to obtain consent from consumers before processing sensitive data. Sensitive data is defined to include the processing of genetic or biometric data for the purpose of uniquely identifying a natural person. Carries over to 2022 session. |
| Minnesota | 2021 State Bills Minnesota 2021 SF 215NHGRI archive2021 legislative sessionPrimary source | Other Topics | Pending | Establishes a grant program within the health department to award grants to persons, organizations, and entities to fund research studies on the evidence needed to: (1) support payer reimbursement and funding of pharmacogenomics (PGx) testing; (2) determine and validate new PGx variants in diverse populations such as Native Americans and Somali groups; (3) determine ethical, legal, and social implications of PGx; (4) determine the technical aspects needed to protect data and privacy as it relates to PGx; and (5) determine the education needed for successful PGx implementation. Carries over to 2022 session. |
| Minnesota | 2021 State Bills Minnesota 2021 SF 2320NHGRI archive2021 legislative sessionPrimary source | Health Insurance Coverage | Pending | Requires every policy, plan, certificate, or contract referred to in subdivision that provides coverage to a Minnesota resident to provide coverage for all diagnostic and preventive screenings and tests related to breast cancer, including but not limited to genetic testing, breast examination, mammography, magnetic resonance imaging, digital breast tomosynthesis, ultrasound, thermography, biopsy, and other breast cancer screening tests currently being evaluated by the federal Food and Drug Breast Cancer research Foundation. Carries over to 2022 session. |
| Minnesota | 2021 State Bills Minnesota 2021SF 248NHGRI archive2021 legislative sessionPrimary source | Other Topics | Pending | Requires the Minnesota Board of Pharmacy to establish a pharmacogenomics task force to evaluate and assess the current availability of pharmacogenomics statewide and to develop recommendations for making pharmacogenomics available statewide. Carries over to 2022 session. |
| Minnesota | 2020 State Bills Minnesota 2020 HF 3096NHGRI archive2020 legislative sessionPrimary source | Privacy | Died | Establishes requirements with regard to collection, sale of, and access to personal information by businesses. Personal information is defined to include genetic information. Died. |
| Minnesota | 2020 State Bills Minnesota 2020 HF 3645NHGRI archive2020 legislative sessionPrimary source | Privacy | Died | Establishes the parent's bill of rights. Requirements set forth in the bill include parental written consent before any record of a minor child's blood or DNA is made, shared or stored unless required by law or court order. Died. |
| Minnesota | 2020 State Bills Minnesota 2020 HF 3936NHGRI archive2020 legislative sessionPrimary source | Privacy | Died | The controller of a legal entity that conducts business in the state may not process sensitive data concerning a consumer without obtaining the consumer's consent, or, in the case of the processing of personal data concerning a known child, without obtaining consent from the child's parent or lawful guardian, in accordance with the children's online privacy protection act requirements. Sensitive data is defined to include genetic or biometric data for the purpose of uniquely identifying a person. The law does not apply to various types of information and entities such as protected health information under HIPAA and identifiable private information according to federal policy for the protection of human subjects. Died. |
| Minnesota | 2020 State Bills Minnesota 2020 SF 3513NHGRI archive2020 legislative sessionPrimary source | Privacy | Died | Establishes the parent's bill of rights. Requirements set forth in the bill include parental written consent before any record of a minor child's blood or DNA is made, shared or stored unless required by law or court order. Died. |
| Minnesota | 2020 State Bills Minnesota 2020 SF 4247NHGRI archive2020 legislative sessionPrimary source | Privacy | Died | Establishes the Minnesota Consumer Data privacy Act. Gives various rights to consumers regarding personal data. Personal data includes the processing of genetic or biometric data for the purpose of uniquely identifying a person. Places obligations on businesses regarding consumer data. Died. |
| Minnesota | 2019 State Bills Minnesota 2019 HF 1048NHGRI archive2019 legislative sessionPrimary source | Other Topics | Died | Establishes a pharmacogenetics task force. Died. |
| Minnesota | 2019 State Bills Minnesota 2019 HF 112NHGRI archive2019 legislative sessionPrimary source | Privacy | Died | Modifies existing law pertaining to the use of genetic information by government entities and enacts a new consumer protection law regarding the use of genetic information. Died. |
| Minnesota | 2019 State Bills Minnesota 2019 HF 2917NHGRI archive2019 legislative sessionPrimary source | Privacy | Died | Businesses must conduct risk assessments of processing activities that involve sensitive consumer data, including genetic data. Died. |
| Minnesota | 2019 State Bills Minnesota 2019 SF 1883NHGRI archive2019 legislative sessionPrimary source | Other Topics | Died | Establishes a pharmacogenetics task force. Died. |
| Minnesota | 2019 State Bills Minnesota 2019 SF 2912NHGRI archive2019 legislative sessionPrimary source | Privacy | Died | Businesses must conduct risk assessments of processing activities that involve sensitive consumer data, including genetic data. Died. |
| Minnesota | 2017 State Bills Minnesota 2017 HF 402/SF 613NHGRI archive2017 legislative sessionPrimary source | Other Topics | Died | Establishes a genetic marker testing pilot program. The program is intended to refine the understanding of disease onset and progression, treatment response, and health outcomes through more precise measurement of genetic factors that contribute to health and disease. Died. |